|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows Used in Operating Activities | |||||
| Net loss | |||||
| Adjustment to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of intangible assets | |||||
| Amortization of right-of-use asset | |||||
| Non-cash interest (income) expense, net | |||||
| Stock-based compensation | |||||
| Amortization of warrant liability to redemption value | |||||
| Impairment of goodwill | |||||
| Impairment of intangible assets | |||||
| Provision for credit losses | |||||
| Provision for inventory obsolescense | |||||
| Loss on conversion of note receivable to equity investment | |||||
| Unrealized loss on equity investment | |||||
| Change in fair value of JV obligation | |||||
| Change in fair value of convertible notes payable | |||||
| Change in fair value of derivative asset | |||||
| Change in fair value of warrant asset | |||||
| Amortization of debt discount | |||||
| Warrant inducement expense | |||||
| Loss on discontinued operations | |||||
| Unrealized (gain)/loss on foreign currency transactions | |||||
| Gain on settlement with FOXO | |||||
| Amortization of debt issuance costs | |||||
| Earnout payment expense benefit | |||||
| Total earnout payment expense benefit | |||||
| Accrued interest income, related party | |||||
| Deferred income tax | |||||
| Unrealized (gain)/loss on equity securities | |||||
| Impairment of goodwill and intangibles | |||||
| Distribution of equity method investment shares to employees as compensation | |||||
| Loss on exchange of debt for equity | |||||
| Realized loss on sale of equity securities | |||||
| Gain on conversion of note receivable | |||||
| Loss on extinguishment of debt | |||||
| Warrant issuance expense | |||||
| Change in fair value of warrant liability | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable and other receivables | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Related party payables | |||||
| Accrued expenses and other current liabilities | |||||
| Income tax liabilities | |||||
| Accrued interest | |||||
| Customer deposits | |||||
| Deferred revenue | |||||
| Operating lease obligation | |||||
| Net Cash Used in Operating Activities | |||||
| Cash Flows (Used in) Provided by Investing Activities | |||||
| Purchase of property and equipment | |||||
| Investment in capitalized software | |||||
| Sales of treasury bills | |||||
| Sales of equity securities | |||||
| Purchases of convertible note | |||||
| Cash received in purchase of Inpixon | |||||
| Proceeds from repayment of note receivable | |||||
| Issuance of Convertible Note Receivable and Warrants | |||||
| Acquisition of Drone Nerds, net of cash acquired | |||||
| Purchase of intangible asset | |||||
| Net Cash (Used in) Provided by Investing Activities | |||||
| Cash Flows Provided by Financing Activities | |||||
| Net proceeds from issuance of preferred stock and warrants | |||||
| Net proceeds from sale of common stock and pre-funded warrants via public offerings | |||||
| Net proceeds from ATM stock offerings | |||||
| Taxes paid related to net share settlement of restricted stock units | |||||
| Net proceeds from issuance of warrants | |||||
| Distribution to shareholders related to Spin-off of CXApp | |||||
| Distribution to trust related to spin off of Grafiti Holding | |||||
| Common shares issued for exercise of warrants | |||||
| Common shares issued for net proceeds from warrants | |||||
| Net proceeds from issuance of convertible notes | |||||
| Net proceeds from issuance of Series 10 Convertible Preferred Stock | |||||
| Net proceeds from the exercise of equity classified warrants | |||||
| Net proceeds from issuance of promissory notes | |||||
| Net proceeds from loan from Inpixon (prior to merger) | |||||
| Redemptions of Series 9 Preferred Stock | |||||
| Series 7 Preferred Stock | |||||
| Series 8 Preferred Stock | |||||
| Total redemptions of Series 9 Preferred Stock | |||||
| Repayment of CXApp acquisition liability | |||||
| Repayments of debt | |||||
| Net Cash Provided by Financing Activities | |||||
| Effect of Foreign Exchange Rate on Changes on Cash | |||||
| Net Increase in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents – Beginning of year | |||||
| Cash and Cash Equivalents – End of year | |||||
| Supplemental Disclosure of cash flow information: | |||||
| Interest | |||||
| Income Taxes | |||||
| Non-cash investing and financing activities | |||||
| Common shares issued for extinguishment of debt | |||||
| Common shares issued for conversion of debt and accrued interest | |||||
| Common shares issued for conversion of debt | |||||
| Common shares issued in exchange of warrants and cashless exercise of warrants and options | |||||
| Deemed dividend related to December 2024 warrant exchange | |||||
| Common shares issued as settlement of accrued compensation | |||||
| Common shares issued as prepayment for services | |||||
| Issuance of common stock for merger consideration, net of cash received | |||||
| Right of use asset obtained in exchange for lease liability | |||||
| Noncash net assets distribution to shareholders related to Spin-off | |||||
| CxApp | |||||
| Grafiti Holdings | |||||
| Investment in equity securities through conversion of note receivable | |||||
| Common shares issued for CXApp acquisition | |||||
| Noncash debt modification fees | |||||
| Marketable securities received for settlement of FOXO | |||||
| Noncash exercise of liability classified warrants to common shares | |||||
| Changes in non-controlling interest due to capital contribution | |||||
| Common shares issued in exchange for warrants | |||||
| Capital contribution - forgiveness of related party payable | |||||
| Common shares issued in exchange of Series 9 preferred stock | |||||
| Capital contribution – forgiveness of related party payable | |||||
| Common shares issued in exchange of Series 9 Preferred Stock exchange | |||||
| Series 9 Preferred Stock dividend accrued | |||||
| Deemed dividend related to Series 9 preferred stock exchange | |||||
| Conversion of accrued interest to Series 9 Preferred Stock | |||||
| Conversion of convertible note receivable to equity investment | |||||
| ATM proceeds withheld as payment towards accounts payable | |||||
| Warrants issued with convertible notes | |||||
| Warrants issued with common stock | |||||
| Reclassification of JV obligation to equity | |||||
| Conversion of accrued interest to convertible note payable | |||||
| Series 10 Convertible Preferred Stock dividend accrued | |||||
| Placement agent warrants issued in Series 10 financing | |||||
| Issuance of Class B Units in connection with acquisition | |||||
| Issuance of promissory notes in connection with acquisition | |||||
| Cash and cash equivalents | |||||
| Cash included in current assets of discontinued operations | |||||
| Cash and Cash Equivalents - End of Year | |||||
Loading...